• roche logo

The cobas® HPV Test: 3 hrHPV results in one test for confident risk stratification1

cobas® HPV Test 3 in 1

The detail to make decisions based upon your patient’s real risk

Trust cobas® HPV Test, a clinically validated FDA-approved and CE-marked assay that identifies high-risk HPV with simultaneous individual genotyping of the most oncogenic HPV16 and HPV18.

The cobas® HPV Test has the potential to set a new standard of testing:

  • Significantly enhances risk stratification
  • Lets you focus on the few women who need aggressive treatment
  • Lets you reassure the vast majority of women that they are at very low risk

Confidence with the cobas® HPV Test

Precise results you can trust

The cobas® HPV Test offers:

  • No cross-reactivity with low-risk HPV types
  • Results are positive, negative, or invalid with no gray zone
  • Reproducible results with real-time PCR

Reduced false negatives1

  • ß-globin internal control for sample adequacy

Reduced false positives1

  • External control
  • No cross-reactivity with low-risk HPV genotypes

For additional technical specifications on the cobas® HPV Test, visit molecular.roche.com

  • Acronyms:


1. cobas® 4800 HPV Test US package insert. April 2011.